I feel for you. Been there. The annual report will come out next...

I feel for you. Been there. The annual report will come out next month or so. Then we have some supposed commercial deals in the US by the end of CY 2023. Honestly speaking, if they announce a deal in the coming weeks, all people will start to sing the LDX song again. I am sure (subjective) some US deals will come through because FDA approval clears the way, and they have a practical product. Dropping the price doesn't mean the product has lost its value. Whenever a pharma goes public, FDA approval seems like a gold standard for their products.

I still think they will get a takeover offer soon by some big fish for their technology and FDA approval.